Featured Post

Hearing Aids Market Size is Worth USD 8,967.7 Mn by 2027

Global Hearing Aids Market is estimated at USD 5,480.1 Million in 2019 and expected to reach USD 8,967.7 Million by 2027 growing at a CAGR of 6.3%, according to a new report by Emergen Research. The hearing aids market is experiencing a rapid growth attributable to the increasing application of beh…

Dexcom Signs Five Years Collaboration Agreement with the University of Virginia

DexCom announced it has signed a five-year collaboration agreement with the University of Virginia to advance its research and development efforts on continuous glucose monitoring-based solutions. Th…

ProAmpac and Metropolitan Tea Collaborate to Introduce Package Made with 100% Home and Industrial Compostable Materials

ProAmpac announced the release of their pioneering ProActive Compostable package designed in collaboration with Metropolitan Tea.   Adam Grose, Chief commercial officer for ProAmpac Said:  Collaborat…

FDA Grants AT-007 Pediatric Rare Disease Designation and Orphan Designation for Treatment of PMM2-CDG

Applied Therapeutics announces today that the U.S. Food and Drug Administration (FDA) has granted AT-007 both Pediatric Rare Disease Designation and Orphan Drug Designation for treatment of PMM2-CDG.…

Mereo BioPharma Receives FDA Rare Pediatric Disease Designation for Setrusumab for the Treatment of Osteogenesis Imperfecta

Mereo BioPharma announces that the U.S. Food and Drug Administration (“FDA”) has granted Rare Pediatric Disease designation to setrusumab for the treatment of osteogenesis imperfecta (“OI”). Setrusum…

Bausch Health Announces VYZULTA® is Now Approved In Seven Countries

Bausch Health announced that VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, has received regulatory approval in Ukraine, bringing the total number of countries where VYZULTA is approved…

MediciNova Announces Positive Clinical Results Regarding MN-166 (ibudilast) for Prevention of Chemotherapy-induced Peripheral Neuropathy Published in Cancer Chemotherapy and Pharmacology

MediciNova today announces positive clinical findings published in Cancer Chemotherapy and Pharmacology regarding MN-166 (ibudilast) as a treatment for prevention of chemotherapy-induced peripheral n…
Newest Older
Subscribe Our Newsletter